RHYTHM PHARMACEUTICALS ANNOUNCES NICE GUIDANCE FOR IMCIVREE® (SETMELANOTIDE) UPDATED TO INCLUDE ADULTS LIVING WITH BARDET-BIEDL SYNDROME

Reuters · 21h ago

Please log in to view news